12:00 AM
 | 
Jun 09, 2014
 |  BC Week In Review  |  Company News  |  Deals

Nuclea Biotechnologies Inc., Thermo Fisher deal

The companies partnered to develop multiplexed research methods for high throughput quantification of native insulin and its therapeutic analogs. The companies said monitoring...

Read the full 94 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >